Codice QR

A prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arthritis on a stable dose of methotrexate

Objective: The objective of this study was to compare efficacy, safety, and immunogenicity between the biosimilar adalimumab (AdaliRel) and the reference innovator product in moderate-to-severe rheumatoid arthritis (RA) patients on stable dose of methotrexate (MTX). Methods: Patients with moderate-t...

Descrizione completa

Salvato in:
Autori principali: Prasad Apsangikar, Sunil Chaudhry, Manoj Naik, Shashank Deoghare, Jamila Joseph
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publishing 2018-01-01
Serie:Indian Journal of Rheumatology
Soggetti:
American College of Rheumatology
biosimilar
biosimilar adalimumab
double-blind
reference adalimumab
rheumatoid arthritis
Accesso online:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=2;spage=84;epage=89;aulast=Apsangikar
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi